FDx Advisors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
NAMA
ACH
FDx Advisors's VCYT Position: Q3 2023 in Review
FDx Advisors sold out of Veracyte (VCYT) in Q3 2023, closing a stake of 8,586 shares — an estimated $219K sold.
FDx Advisors first reported a position in VCYT in Q4 2021 and held it in 3 quarters. The position peaked at $244K in Q4 2021. 236 funds tracked by Wall St. Rank hold VCYT as of Q3 2023.
- FDx Advisors reported no remaining Veracyte position as of Q3 2023 after selling out during the quarter.
- FDx Advisors sold 8,586 Veracyte shares in Q3 2023, an estimated $219K.
- FDx Advisors first reported a position in Veracyte in Q4 2021 and held it in 3 quarters.
- FDx Advisors's Veracyte position peaked at $244K in Q4 2021.
- 236 funds tracked by Wall St. Rank held Veracyte as of Q3 2023.
Based on FDx Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.